Skip to main content
. 2010 May-Jun;17(3):308–312. doi: 10.1136/jamia.2009.001537

Table 1.

Patient characteristics

Pre-intervention Post-intervention
N 509 492
No of men 292 300
Age (years) 77.9±11.2 78.6±12.4
Weight (kg) 73.9±17.8 72.7±19.9
Length of stay (median, range) 7 (1–154) 7 (1–84)
Co-morbidities (median, range) 3 (0–12) 3 (0–9)
Renal function at admission* (ml/min) 47.4+24.1 43.3+22.7
ARF (n) 24 16
ACEI (n) 258 252
Allopurinol (n) 50 54
Digoxin (n) 98 80
Enoxaparin (n) 44 58
Furosemide (n)* 204 233
Gentamicin (n)* 77 38
Lithium (n) 1 1
Metformin (n) 64 60
Vancomycin (n)* 37 17

Mean (±1 SD) unless otherwise stated.

*

p<0.05 for difference between pre and post-intervention period.

ACEI, angiotensin-converting enzyme inhibitor; ARF, acute renal failure.